Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Daniel Echeverría-Esnal, Clara Martin-Ontiyuelo, María Eugenia Navarrete-Rouco, Marta De-Antonio Cuscó, Olivia Ferrández, Juan Pablo Horcajada & Santiago Grau. (2021) Azithromycin in the treatment of COVID-19: a review. Expert Review of Anti-infective Therapy 19:2, pages 147-163.
Read now
Read now
George A. Margaritopoulos, Maria A. Kokosi & Athol U. Wells. (2019) Diagnosing complications and co-morbidities of fibrotic interstitial lung disease. Expert Review of Respiratory Medicine 13:7, pages 645-658.
Read now
Read now
Kazuya Tsubouchi, Jun Araya, Shunsuke Minagawa, Hiromichi Hara, Akihiro Ichikawa, Nayuta Saito, Tsukasa Kadota, Nahoko Sato, Masahiro Yoshida, Yusuke Kurita, Kenji Kobayashi, Saburo Ito, Yu Fujita, Hirofumi Utsumi, Haruhiko Yanagisawa, Mitsuo Hashimoto, Hiroshi Wakui, Yutaka Yoshii, Takeo Ishikawa, Takanori Numata, Yumi Kaneko, Hisatoshi Asano, Makoto Yamashita, Makoto Odaka, Toshiaki Morikawa, Katsutoshi Nakayama, Yoichi Nakanishi & Kazuyoshi Kuwano. (2017) Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4. Autophagy 13:8, pages 1420-1434.
Read now
Read now
Articles from other publishers (38)
Atukuri Dorababu & Manikantha Maraswami. (2023) Recent Advances (2015–2020) in Drug Discovery for Attenuation of Pulmonary Fibrosis and COPD. Molecules 28:9, pages 3674.
Crossref
Crossref
Rebecca J. Calthorpe, Caroline Poulter, Alan R. Smyth, Don Sharkey, Jayesh Bhatt, Gisli Jenkins & Amanda L. Tatler. (2023) Complex roles of TGF-β signaling pathways in lung development and bronchopulmonary dysplasia. American Journal of Physiology-Lung Cellular and Molecular Physiology 324:3, pages L285-L296.
Crossref
Crossref
Albert Li, Jhih-Yu Chen, Chia-Lang Hsu, Yen-Jen Oyang, Hsuan-Cheng Huang & Hsueh-Fen Juan. (2022) A Single-Cell Network-Based Drug Repositioning Strategy for Post-COVID-19 Pulmonary Fibrosis. Pharmaceutics 14:5, pages 971.
Crossref
Crossref
Jialiang Sun & Yanan Li. (2021) Long-term, low-dose macrolide antibiotic treatment in pediatric chronic airway diseases. Pediatric Research 91:5, pages 1036-1042.
Crossref
Crossref
Dong Soon Kim. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
199
217
.
Andrea Sauer, Konrad Peukert, Christian Putensen & Christian Bode. (2021) Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment. European Respiratory Review 30:162, pages 210093.
Crossref
Crossref
Sabina A. Guler, Christian ClarenbachMartin Brutsche, Katrin Hostettler, Anne-Kathrin BrillAnke SchertelThomas K. GeiserManuela Funke-Chambour. (2021) Azithromycin for the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis: A Randomized Controlled Crossover Trial. Annals of the American Thoracic Society 18:12, pages 2018-2026.
Crossref
Crossref
Xiang Tong, Shijie Zhang, Dongguang Wang, Li Zhang, Jizheng Huang, Tianli Zhang & Hong Fan. (2021) Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2. Frontiers in Pharmacology 12.
Crossref
Crossref
Jennifer A. Kricker, Clive P. Page, Fridrik Runar Gardarsson, Olafur Baldursson, Thorarinn Gudjonsson & Michael J. Parnham. (2022) Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development. Pharmacological Reviews 73:4, pages 1404-1433.
Crossref
Crossref
Andrew M Wilson, Allan B Clark, Anthony Cahn, Edwin R Chilvers, William Fraser, Matthew Hammond, David M Livermore, Toby M Maher, Helen Parfrey, Ann Marie Swart, Susan Stirling, David Thickett & Moira Whyte. (2021) Co-trimoxazole to reduce mortality, transplant, or unplanned hospitalisation in people with moderate to very severe idiopathic pulmonary fibrosis: the EME-TIPAC RCT. Efficacy and Mechanism Evaluation 8:9, pages 1-110.
Crossref
Crossref
Hao Ruan, Shaoyan Gao, Shuangling Li, Jiaoyan Luan, Qiuyan Jiang, Xiaohe Li, Huijun Yin, Honggang Zhou & Cheng Yang. (2021) Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway. Molecules 26:9, pages 2820.
Crossref
Crossref
Ningning Tao, Kang Li, Jingjing Liu, Guoqing Fan & Tieying Sun. (2021) Liproxstatin-1 alleviates bleomycin-induced alveolar epithelial cells injury and mice pulmonary fibrosis via attenuating inflammation, reshaping redox equilibrium, and suppressing ROS/p53/α-SMA pathway. Biochemical and Biophysical Research Communications 551, pages 133-139.
Crossref
Crossref
María Magallón, Sara Pastor, Ana Carrión, Lucía Bañuls, Daniel Pellicer, Silvia Castillo, Sergio Bondía, María Navarro-García, Cruz González & Francisco Dasí. (2021) Oxidative Stress and Endoplasmic Reticulum Stress in Rare Respiratory Diseases. Journal of Clinical Medicine 10:6, pages 1268.
Crossref
Crossref
Kristina Krempaska, Sandra Barnowski, Jacopo Gavini, Nina Hobi, Simone Ebener, Cedric Simillion, Andrea Stokes, Ronja Schliep, Lars Knudsen, Thomas K. Geiser & Manuela Funke-Chambour. (2020) Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls. Respiratory Research 21:1.
Crossref
Crossref
Ángel González. (2020) The Therapy of Pulmonary Fibrosis in Paracoccidioidomycosis: What Are the New Experimental Approaches?. Journal of Fungi 6:4, pages 217.
Crossref
Crossref
Angela C Finato, Débora F Almeida, Amanda R dos Santos, Dejair C Nascimento, Ricardo S Cavalcante, Rinaldo P Mendes, Cléverson T Soares, Anamaria M M Paniago & James Venturini. (2020) Evaluation of antifibrotic and antifungal combined therapies in experimental pulmonary paracoccidioidomycosis. Medical Mycology 58:5, pages 667-678.
Crossref
Crossref
Pengfei Sun, Shuyan Qie, Zongjian Liu, Jizhen Ren, Kun Li & Jianing Xi. (2020) Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: A single arm meta‐analysis. Journal of Medical Virology 92:6, pages 612-617.
Crossref
Crossref
Eva Otoupalova, Sam Smith, Guangjie Cheng & Victor J. Thannickal. 2011. Comprehensive Physiology. Comprehensive Physiology
509
547
.
Andrew J. Thorley, Simon Krautwald & David J. Rowlands. 2020. Anti-fibrotic Drug Discovery. Anti-fibrotic Drug Discovery
165
184
.
Xiaolin Yu, Yanxia Zhang, Xiaohua Yang, Xiaomei Zhang, Xinxiang Wang, Xuemei Liu & Yan Yan. (2018) The Influence of BuqiHuoxueTongluo Formula on Histopathology and Pulmonary Function Test in Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats. Evidence-Based Complementary and Alternative Medicine 2018, pages 1-13.
Crossref
Crossref
Hiroyoshi Tsubochi, Tomoki Shibano & Shunsuke Endo. (2017) Recommendations for perioperative management of lung cancer patients with comorbidities. General Thoracic and Cardiovascular Surgery 66:2, pages 71-80.
Crossref
Crossref
Kodai Kawamura, Kazuya Ichikado, Yuko Yasuda, Keisuke Anan & Moritaka Suga. (2017) Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study. BMC Pulmonary Medicine 17:1.
Crossref
Crossref
Sunad Rangarajan, Karen Bernard & Victor J. Thannickal. (2017) Mitochondrial Dysfunction in Pulmonary Fibrosis. Annals of the American Thoracic Society 14:Supplement_5, pages S383-S388.
Crossref
Crossref
Hye-Shin Park, Yong Sun Lee, Eun-Young Choi, Jeom-Il Choi, In Soon Choi & Sung-Jo Kim. (2017) Subantibiotic dose of azithromycin attenuates alveolar bone destruction and improves trabecular microarchitectures in a rat model of experimental periodontitis: A study using micro-computed tomography. International Immunopharmacology 47, pages 212-217.
Crossref
Crossref
George A. Margaritopoulos, Katerina M. Antoniou & Athol U. Wells. (2017) Comorbidities in interstitial lung diseases. European Respiratory Review 26:143, pages 160027.
Crossref
Crossref
Davide Biondini & Paolo Spagnolo. 2017. Anti-infectives and the Lung. Anti-infectives and the Lung
264
275
.
Hiroyuki Taniguchi & Yasuhiro Kondoh. (2016) Acute and subacute idiopathic interstitial pneumonias. Respirology 21:5, pages 810-820.
Crossref
Crossref
Changkyu Lee, Jisoo Seo, Ha Shin Hwang, Le Quang Thao, Seunghyun Lee, Eun Seong Lee, Eun Hee Lee, Han-Gon Choi & Yu Seok Youn. (2016) Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles. Biomedicine & Pharmacotherapy 78, pages 226-233.
Crossref
Crossref
Sunad Rangarajan, Morgan L. Locy, Tracy R. Luckhardt & Victor J. Thannickal. (2016) Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?. Drugs 76:3, pages 291-300.
Crossref
Crossref
Eva Cecrdlova, Katerina Petrickova, Libor Kolesar, Miroslav Petricek, Alena Sekerkova, Veronika Svachova & Ilja Striz. (2016) Manumycin A downregulates release of proinflammatory cytokines from TNF alpha stimulated human monocytes. Immunology Letters 169, pages 8-14.
Crossref
Crossref
Steven D Nathan, A Whitney Brown & Christopher S KingSteven D Nathan, A Whitney Brown & Christopher S King. 2016. Guide to Clinical Management of Idiopathic Pulmonary Fibrosis. Guide to Clinical Management of Idiopathic Pulmonary Fibrosis
111
123
.
Michael J. Parnham, Vesna Erakovic Haber, Evangelos J. Giamarellos-Bourboulis, Gianpaolo Perletti, Geert M. Verleden & Robin Vos. (2014) Azithromycin: Mechanisms of action and their relevance for clinical applications. Pharmacology & Therapeutics 143:2, pages 225-245.
Crossref
Crossref
Robin Vos, Stijn E. Verleden, David Ruttens, Bart M. Vanaudenaerde & Geert M. Verleden. 2013. Bronchiolitis Obliterans Syndrome in Lung Transplantation. Bronchiolitis Obliterans Syndrome in Lung Transplantation
277
295
.
Balarka Banerjee, Michael Musk, Erika N. Sutanto, Stephanie T. Yerkovich, Peter Hopkins, Darryl A. Knight, Suzanna Lindsey-Temple, Stephen M. Stick, Anthony Kicic & Daniel C. Chambers. (2012) Regional Differences in Susceptibiity of Bronchial Epithelium to Mesenchymal Transition and Inhibition by the Macrolide Antibiotic Azithromycin. PLoS ONE 7:12, pages e52309.
Crossref
Crossref
Robin Vos, Bart M. Vanaudenaerde, Stijn E. Verleden, David Ruttens, Annemie Vaneylen, Dirk E. Van Raemdonck, Lieven J. Dupont & Geert M. Verleden. (2012) Anti-Inflammatory and Immunomodulatory Properties of Azithromycin Involved in Treatment and Prevention of Chronic Lung Allograft Rejection. Transplantation 94:2, pages 101-109.
Crossref
Crossref
Marios A. Mouratis & Vassilis Aidinis. (2011) Modeling pulmonary fibrosis with bleomycin. Current Opinion in Pulmonary Medicine 17:5, pages 355-361.
Crossref
Crossref
Lo?c Guillot, Olivier Tabary, Nadia Nathan, Harriet Corvol & Annick Clement. (2011) Macrolides: New therapeutic perspectives in lung diseases. The International Journal of Biochemistry & Cell Biology 43:9, pages 1241-1246.
Crossref
Crossref
Rupa Biswas, Melisa Bunderson-Schelvan & Andrij Holian. (2011) Potential Role of the Inflammasome-Derived Inflammatory Cytokines in Pulmonary Fibrosis. Pulmonary Medicine 2011, pages 1-8.
Crossref
Crossref